Drawing for PROTEGA

USPTO serial 99151046

PROTEGA

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SWIFT, GILBERT M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with PROTEGA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian J. Focarino

Brian J. Focarino Cooley LLP1299 Pennsylvania Avenue NW, Suite 700Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic blood or biopsy testing assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; all of the goods related to the field of organ transplantsACTIVE—
010Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients; all of the goods related to the field of organ transplantsACTIVE—
042Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; all of the services related to the field of organ transplantsACTIVE—
044Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies for predicting and identifying risk of graft rejection in kidney transplant patients; healthcare, namely, medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 17, 2026EX1GSOU EXTENSION 1 GRANTED—
Sep 17, 2026EXT1SOU EXTENSION 1 FILED—
Sep 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Dec 18, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 18, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 18, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2025DOCKASSIGNED TO EXAMINER—
Aug 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 23, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance